Acucela

News

 

2010
Nov	Oct	Sept	Aug	July	June	May

 

11/16/10 Otsuka to announce that they have filed for regulatory approval in Japan for
              rebamipide ophthalmic suspension for dry eye

 

We are pleased to announce Otsuka Pharmaceutical’s release of news on November 9, 2010 that they have filed regulatory approval in Japan for rebamipide ophthalmic suspension for dry eye. Acucela and Otsuka are co-developing rebamipide for the treatment of dry eye in the United States.